Microbiology Department Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland; Clinical Microbiology Laboratory, University Hospital No. 1 in Bydgoszcz, Bydgoszcz, Poland.
Microbiology Department Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland; Clinical Microbiology Laboratory, University Hospital No. 1 in Bydgoszcz, Bydgoszcz, Poland.
J Hosp Infect. 2021 Jun;112:21-26. doi: 10.1016/j.jhin.2021.03.008. Epub 2021 Mar 16.
Streptococcus agalactiae (group B streptococcus: GBS) is a leading cause of early- and late-onset diseases in neonates. Reliable results of GBS carriage investigation among pregnant women may decrease the incidence of neonatal infection and mortality.
To compare the results of conventional culture investigation with those of the US Food and Drug Administration-approved nucleic acid amplification test (BD Max GBS (Becton Dickinson)), and to establish our own protocols of standard polymerase chain reaction (PCR).
A total of 250 vaginal-rectal swabs from three different hospitals in Bydgoszcz, Poland, were used to evaluate GBS carriage. Standard laboratory technique (overnight culture in broth enrichment media) results were compared with those of BD Max GBS assay (Becton Dickinson) and two standard PCR protocols, established to detect the cfb and 16S rRNA S. agalactiae genes, from the overnight cultures of the samples in the liquid enrichment media.
The overall GBS carriage was estimated as 16.4-23.2%, depending on the applied detection method. The highest percentage of positive results, from each lab-oratory was obtained with the application of BD Max GBS assay. The differences in the number of positive results obtained with this particular method were statistically significant. Overall, 27 discrepancies were noted for the results obtained with the application of the methods compared.
The methods applied for GBS detection differ in sensitivity. A culture technique, though very specific, appears to be less sensitive at detecting S. agalactiae compared with the commercially available BD Max GBS assay or in-house PCR protocols established for this purpose.
B 群链球菌(无乳链球菌:GBS)是导致新生儿早发性和晚发性疾病的主要原因。可靠的孕妇 GBS 携带调查结果可降低新生儿感染和死亡率。
比较传统培养调查结果与美国食品和药物管理局批准的核酸扩增试验(BD Max GBS(贝克顿·迪金森))的结果,并建立我们自己的标准聚合酶链反应(PCR)协议。
使用来自波兰比得哥什的三家不同医院的 250 份阴道直肠拭子来评估 GBS 携带情况。将标准实验室技术(过夜培养在肉汤富集培养基中)的结果与 BD Max GBS 检测(贝克顿·迪金森)和两个标准 PCR 协议的结果进行比较,这两个协议是为检测液体富集培养基中样本的 cfb 和 16S rRNA S.agalactiae 基因而建立的。
根据应用的检测方法,GBS 携带率估计为 16.4-23.2%。应用 BD Max GBS 检测时,每个实验室获得的阳性结果百分比最高。应用该特定方法获得的阳性结果数量差异具有统计学意义。总体而言,在应用比较方法时注意到了 27 个结果差异。
用于 GBS 检测的方法在灵敏度上存在差异。尽管培养技术非常特异,但与市售的 BD Max GBS 检测或为此目的建立的内部 PCR 协议相比,检测 S.agalactiae 的灵敏度似乎较低。